Comparative sensitivities of Sabin and Mahoney poliovirus type 1 prototype strains and two recent isolates to low concentrations of glutaraldehyde.
Significant intratypic differences in the glutaraldehyde (GTA) sensitivity of echovirus isolates have been shown. While exploring ways to optimize the study of GTA sensitivity of enteroviruses, we also observed intratypic differences in poliovirus type 1 isolates collected in France. A suspension procedure was used for assessing the virucidal effect of GTA at low concentrations (< or = 0.10%) against purified viruses. Two recent isolates of poliovirus type 1 tested were first fully characterized by the PCR restriction fragment length polymorphism (RFLP) test. The RFLP pattern of clinical isolate 5617 was similar to that of poliovirus type 1 LS-c, 2ab (Sabin strain), confirming the vaccine origin of strain 5617. The RFLP pattern of strain 5915 recovered from sewage was different from that of the Mahoney strain, suggesting a genetic variation in this wild isolate. We then analyzed under the same controlled conditions the GTA sensitivities of both isolates and their respective prototype strains. The wild Mahoney and 5915 strains exhibited significantly lower sensitivities to GTA than did the vaccine Sabin and 5617 strains. The inactivation rates of clinical isolates 5617 and 5915 were very similar to those of their corresponding reference Sabin and Mahoney strains. Both the conformational structure of the capsid of each strain and the amino acid constitution of structural polypeptides could be involved in the variations observed. The relevance of our comparative sensitivity studies to standardization of virucidal tests is discussed.
Chambon
M
M
Laboratoire de Bactériologie-Virologie, Faculté de Médecine et Pharmacie, Clermont-Ferrand, France.
Jallat-Archimbaud
C
C
Bailly
J L
JL
Gourgand
J M
JM
Charbonne
F
F
Henquell
C
C
Fuchs
F
F
Peigue-Lafeuille
H
H
D000818:Animals; D002478:Cells, Cultured; D002522:Chlorocebus aethiops; D005976:Glutaral / Q000494:pharmacology*; D007700:Kinetics; D011051:Poliomyelitis / Q000235:genetics / Q000821:virology*; D017955:Poliovirus / Q000187:drug effects* / Q000235:genetics* / Q000254:growth & development; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics; D012044:Regression Analysis; D015183:Restriction Mapping; D014709:Vero Cells
D012367:RNA, Viral; D005976:Glutaral